JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 22, 2006; DOI: 10.1124/jpet.106.111385


0022-3565/06/3193-1051-1061$20.00
JPET 319:1051-1061, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.111385v1
319/3/1051    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LoVerme, J.
Right arrow Articles by Piomelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LoVerme, J.
Right arrow Articles by Piomelli, D.

NEUROPHARMACOLOGY

Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-{alpha}

Jesse LoVerme, Roberto Russo, Giovanna La Rana, Jin Fu, Jesse Farthing, Giuseppina Mattace-Raso, Rosaria Meli, Andrea Hohmann, Antonio Calignano, and Daniele Piomelli

Department of Pharmacology and the Center for Drug Discovery, University of California, Irvine, California (J.L., J.F. D.P.); Department of Experimental Pharmacology, University of Naples, Naples, Italy (R.R., G.L., G.M.R., R.M., A.C.); and Department of Psychology, University of Georgia, Athens, Georgia (J.F., A.H.)

Severe pain remains a major area of unmet medical need. Here we report that agonists of the nuclear receptor PPAR-{alpha} (peroxisome proliferator-activated receptor-{alpha}) suppress pain behaviors induced in mice by chemical tissue injury, nerve damage, or inflammation. The PPAR-{alpha} agonists GW7647 [2-(4-(2-(1-cyclohexanebutyl)-3-cyclohexylureido)ethyl)phenylthio)-2-methylpropionic acid], Wy-14643 [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid], and palmitoylethanolamide (PEA) reduced nocifensive behaviors elicited in mice by intraplantar (i.pl.) injection of formalin or i.p. injection of magnesium sulfate. These effects were absent in PPAR-{alpha}-null mice yet occurred within minutes of agonist administration in wild-type mice, suggesting that they were mediated through a transcription-independent mechanism. Consistent with this hypothesis, blockade of calcium-operated IKca (KCa3.1) and BKca (KCa1.1) potassium channels prevented the effects of GW7647 and PEA in the formalin test. Three observations suggest that PPAR-{alpha} agonists may inhibit nocifensive responses by acting on peripheral PPAR-{alpha}. (i) PEA reduced formalin-induced pain at i.pl. doses that produced no increase in systemic PEA levels; (ii) PPAR-{alpha} was expressed in dorsal root ganglia neurons of wild-type but not PPAR-{alpha}-null mice; and (ii) GW7647 and PEA prevented formalin-induced firing of spinal cord nociceptive neurons in rats. In addition to modulating nociception, GW7647 and PEA reduced hyperalgesic responses in the chronic constriction injury model of neuropathic pain; these effects were also contingent on PPAR-{alpha} expression and were observed following either acute or subchronic PPAR-{alpha} agonist administration. Finally, acute administration of GW7647 and PEA reduced hyperalgesic responses in the complete Freund's adjuvant and carrageenan models of inflammatory pain. Our results suggest that PPAR-{alpha} agonists may represent a novel class of analgesics.


Received July 24, 2006; accepted September 21, 2006.

Address correspondence to: Dr. Daniele Piomelli, Department of Pharmacology, University of California, Irvine, 360 MSRII, Irvine, CA 92697-4625. E-mail: piomelli{at}uci.edu




This article has been cited by other articles:


Home page
Learn. Mem.Home page
C. Mazzola, J. Medalie, M. Scherma, L. V. Panlilio, M. Solinas, G. Tanda, F. Drago, J. L. Cadet, S. R. Goldberg, and S. Yasar
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-{alpha} nuclear receptors
Learn. Mem., April 29, 2009; 16(5): 332 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. J. Lever, M. Robinson, M. Cibelli, C. Paule, P. Santha, L. Yee, S. P. Hunt, B. F. Cravatt, M. R. Elphick, I. Nagy, et al.
Localization of the Endocannabinoid-Degrading Enzyme Fatty Acid Amide Hydrolase in Rat Dorsal Root Ganglion Cells and Its Regulation after Peripheral Nerve Injury
J. Neurosci., March 25, 2009; 29(12): 3766 - 3780.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. J. Karbarz, L. Luo, L. Chang, C.-S. Tham, J. A. Palmer, S. J. Wilson, M. L. Wennerholm, S. M. Brown, B. P. Scott, R. L. Apodaca, et al.
Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase
Anesth. Analg., January 1, 2009; 108(1): 316 - 329.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Melis, G. Pillolla, A. Luchicchi, A. L. Muntoni, S. Yasar, S. R. Goldberg, and M. Pistis
Endogenous Fatty Acid Ethanolamides Suppress Nicotine-Induced Activation of Mesolimbic Dopamine Neurons through Nuclear Receptors
J. Neurosci., December 17, 2008; 28(51): 13985 - 13994.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Fu, J. Kim, F. Oveisi, G. Astarita, and D. Piomelli
Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R45 - R50.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. H. Napimoga, G. R. Souza, T. M. Cunha, L. F. Ferrari, J. T. Clemente-Napimoga, C. A. Parada, W. A. Verri Jr., F. Q. Cunha, and S. H. Ferreira
15d-Prostaglandin J2 Inhibits Inflammatory Hypernociception: Involvement of Peripheral Opioid Receptor
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 313 - 321.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. H. Napimoga, S. M. Vieira, D. Dal-Secco, A. Freitas, F. O. Souto, F. L. Mestriner, J. C. Alves-Filho, R. Grespan, T. Kawai, S. H. Ferreira, et al.
Peroxisome Proliferator-Activated Receptor-{gamma} Ligand, 15-Deoxy-{Delta}12,14-Prostaglandin J2, Reduces Neutrophil Migration via a Nitric Oxide Pathway
J. Immunol., January 1, 2008; 180(1): 609 - 617.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. D'Agostino, G. La Rana, R. Russo, O. Sasso, A. Iacono, E. Esposito, G. M. Raso, S. Cuzzocrea, J. Lo Verme, D. Piomelli, et al.
Acute Intracerebroventricular Administration of Palmitoylethanolamide, an Endogenous Peroxisome Proliferator-Activated Receptor-{alpha} Agonist, Modulates Carrageenan-Induced Paw Edema in Mice
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1137 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
N. D. Teaster, C. M. Motes, Y. Tang, W. C. Wiant, M. Q. Cotter, Y.-S. Wang, A. Kilaru, B. J. Venables, K. H. Hasenstein, G. Gonzalez, et al.
N-Acylethanolamine Metabolism Interacts with Abscisic Acid Signaling in Arabidopsis thaliana Seedlings
PLANT CELL, August 1, 2007; 19(8): 2454 - 2469.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Russo, J. LoVerme, G. La Rana, T. R. Compton, J. Parrott, A. Duranti, A. Tontini, M. Mor, G. Tarzia, A. Calignano, et al.
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3'-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 236 - 242.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.